Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract 42: Target inhibitory networks and drug response modeling

Uma Shankavaram, Kevin Camphausen

Clin Cancer Res (2016) 22 (1_Supplement): 42.

https://doi.org/10.1158/1557-3265.PMSCLINGEN15-42

Published: 03 January 2016

View article titled, Abstract 42: Target inhibitory networks and drug response modeling

Journal Articles

Pathways of angiogenic resistance in glioblastoma: Adaptations in growth factor signaling in response to VEGF and HGF attenuation

Christian A. Graves, Kevin Camphausen

Clin Cancer Res (2010) 16 (19_Supplement): B13.

https://doi.org/10.1158/DIAG-10-B13

Published: 15 August 2014

View article titled, Pathways of angiogenic resistance in glioblastoma: Adaptations in growth factor signaling in response to VEGF and HGF attenuation

Journal Articles

The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

Thomas J. Hayman, Amy Wahba, Barbara H. Rath, Heekyong Bae, Tamalee Kramp, Uma T. Shankavaram, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2014) 20 (1): 110–119.

https://doi.org/10.1158/1078-0432.CCR-13-2136

Published: 05 January 2014

View article titled, The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

Includes: Supplementary data

Journal Articles

Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition

Mary Ellen Urick, Eun Joo Chung, William P. Shield, III, Naamit Gerber, Ayla White, Anastasia Sowers, Angela Thetford, Kevin Camphausen, James Mitchell, Deborah E. Citrin

Clin Cancer Res (2011) 17 (15): 5038–5047.

https://doi.org/10.1158/1078-0432.CCR-11-0358

Published: 31 July 2011

View article titled, Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition

Includes: Supplementary data

Journal Articles

Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept

John F. de Groot, Yuji Piao, Hai Tran, Mark Gilbert, Hua-Kang Wu, Jun Liu, B. Nebiyou Bekele, Tim Cloughesy, Minesh Mehta, H. Ian Robins, Andrew Lassman, Lisa DeAngelis, Kevin Camphausen, Alice Chen, WKA Yung, Michael Prados, Patrick Y. Wen, John V. Heymach

Clin Cancer Res (2011) 17 (14): 4872–4881.

https://doi.org/10.1158/1078-0432.CCR-11-0271

Published: 17 July 2011

View article titled, Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept

Includes: Supplementary data

Journal Articles

Microenvironmental Regulation of Glioblastoma Radioresponse

Muhammad Jamal, Barbara H. Rath, Eli S. Williams, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2010) 16 (24): 6049–6059.

https://doi.org/10.1158/1078-0432.CCR-10-2435

Published: 16 December 2010

View article titled, Microenvironmental Regulation of Glioblastoma Radioresponse

Includes: Supplementary data

Journal Articles

Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

Clin Cancer Res (2009) 15 (19): 6148–6157.

https://doi.org/10.1158/1078-0432.CCR-09-1039

Published: 30 September 2009

View article titled, Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

Includes: Supplementary data

Journal Articles

CD133⁺ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

Amy M. McCord, Muhammad Jamal, Eli S. Williams, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2009) 15 (16): 5145–5153.

https://doi.org/10.1158/1078-0432.CCR-09-0263

Published: 12 August 2009

View article titled, CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

Journal Articles

Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer

Andrea L. Russo, Kimberly Jedlicka, Meredith Wernick, Debbie McNally, Melissa Kirk, Mary Sproull, Sharon Smith, Uma Shankavaram, Aradhana Kaushal, William D. Figg, William Dahut, Deborah Citrin, Donald P. Bottaro, Paul S. Albert, Philip J. Tofilon, Kevin Camphausen

Clin Cancer Res (2009) 15 (13): 4292–4298.

https://doi.org/10.1158/1078-0432.CCR-09-0599

Published: 01 July 2009

View article titled, Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer

Journal Articles

In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase

Eun Joo Chung, Aaron P. Brown, Hiroaki Asano, Mariana Mandler, William E. Burgan, Donna Carter, Kevin Camphausen, Deborah Citrin

Clin Cancer Res (2009) 15 (9): 3050–3057.

https://doi.org/10.1158/1078-0432.CCR-08-2954

Published: 30 April 2009

View article titled, In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase

Includes: Supplementary data

Journal Articles

In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Andrea L. Russo, Hyuk-Chan Kwon, William E. Burgan, Donna Carter, Katie Beam, Xu Weizheng, Jie Zhang, Barbara S. Slusher, Arnab Chakravarti, Philip J. Tofilon, Kevin Camphausen

Clin Cancer Res (2009) 15 (2): 607–612.

https://doi.org/10.1158/1078-0432.CCR-08-2079

Published: 15 January 2009

View article titled, In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Journal Articles

Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid

Prakash Chinnaiyan, David Cerna, William E. Burgan, Katie Beam, Eli S. Williams, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2008) 14 (17): 5410–5415.

https://doi.org/10.1158/1078-0432.CCR-08-0643

Published: 02 September 2008

View article titled, Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid

Journal Articles

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

Robert J. Lechleider, Philip M. Arlen, Kwong-Yok Tsang, Seth M. Steinberg, Junko Yokokawa, Vittore Cereda, Kevin Camphausen, Jeffrey Schlom, William L. Dahut, James L. Gulley

Clin Cancer Res (2008) 14 (16): 5284–5291.

https://doi.org/10.1158/1078-0432.CCR-07-5162

Published: 12 August 2008

View article titled, Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

Journal Articles

The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated Killing

Mala Chakraborty, Elizabeth K. Wansley, Jorge A. Carrasquillo, Sarah Yu, Chang H. Paik, Kevin Camphausen, Michael D. Becker, William F. Goeckeler, Jeffrey Schlom, James W. Hodge

Clin Cancer Res (2008) 14 (13): 4241–4249.

https://doi.org/10.1158/1078-0432.CCR-08-0335

Published: 01 July 2008

View article titled, The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated Killing

Journal Articles

In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide

Whoon Jong Kil, David Cerna, William E. Burgan, Katie Beam, Donna Carter, Patricia S. Steeg, Philip J. Tofilon, Kevin Camphausen

Clin Cancer Res (2008) 14 (3): 931–938.

https://doi.org/10.1158/1078-0432.CCR-07-1856

Published: 01 February 2008

View article titled, In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide

Journal Articles

Inhibition of Hsp90: A Multitarget Approach to Radiosensitization

Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2007) 13 (15): 4326–4330.

https://doi.org/10.1158/1078-0432.CCR-07-0632

Published: 01 August 2007

View article titled, Inhibition of Hsp90: A Multitarget Approach to Radiosensitization

Journal Articles

Tumor-Directed Radiation and the Immunotoxin SS1P in the Treatment of Mesothelin-Expressing Tumor Xenografts

Raffit Hassan, Juanita Williams-Gould, Seth M. Steinberg, David J. Liewehr, Junko Yokokawa, Kwong Y. Tsang, Robert J. Surawski, Tamalee Scott, Kevin Camphausen

Clin Cancer Res (2006) 12 (16): 4983–4988.

https://doi.org/10.1158/1078-0432.CCR-06-0441

Published: 16 August 2006

View article titled, Tumor-Directed Radiation and the Immunotoxin SS1P in the Treatment of Mesothelin-Expressing Tumor Xenografts

Journal Articles

In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone)

Christopher A. Barker, William E. Burgan, Donna J. Carter, David Cerna, David Gius, Melinda G. Hollingshead, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2006) 12 (9): 2912–2918.

https://doi.org/10.1158/1078-0432.CCR-05-2860

Published: 04 May 2006

View article titled, In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone)

Journal Articles

Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine

Hideaki Dote, David Cerna, William E. Burgan, Donna J. Carter, Michael A. Cerra, Melinda G. Hollingshead, Kevin Camphausen, Philip J. Tofilon

Clin Cancer Res (2005) 11 (12): 4571–4579.

https://doi.org/10.1158/1078-0432.CCR-05-0050

Published: 15 June 2005

View article titled, Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine

Journal Articles

The Requirement of Multimodal Therapy (Vaccine, Local Tumor Radiation, and Reduction of Suppressor Cells) to Eliminate Established Tumors

Chie Kudo-Saito, Jeffrey Schlom, Kevin Camphausen, C. Norman Coleman, James W. Hodge

Clin Cancer Res (2005) 11 (12): 4533–4544.

https://doi.org/10.1158/1078-0432.CCR-04-2237

Published: 15 June 2005

View article titled, The Requirement of Multimodal Therapy (Vaccine, Local Tumor Radiation, and Reduction of Suppressor Cells) to Eliminate Established Tumors

NARROW

Abstract 42: Target inhibitory networks and drug response modeling

Pathways of angiogenic resistance in glioblastoma: Adaptations in growth factor signaling in response to VEGF and HGF attenuation

The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition

Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept

Microenvironmental Regulation of Glioblastoma Radioresponse

Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

CD133⁺ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer

In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase

In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated Killing

In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide

Inhibition of Hsp90: A Multitarget Approach to Radiosensitization

Tumor-Directed Radiation and the Immunotoxin SS1P in the Treatment of Mesothelin-Expressing Tumor Xenografts

In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone)

Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine

The Requirement of Multimodal Therapy (Vaccine, Local Tumor Radiation, and Reduction of Suppressor Cells) to Eliminate Established Tumors

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only